Massivemarkets

OCGN

Ocugen, Inc. Common Stock

Nasdaq · usd

$0.7397-0.05 (-6.37%)
At close · 15-minute delayed
$0.7500+0.01 (+1.39%)
As of 5:15:12 PM EDT on Oct 23, 2026 · After hours

Ocugen, Inc. Common Stock (OCGN) trades at $0.7397 (-6.37%) as of 5:15:12 PM EDT on Oct 23, 2026, -26.03% over the past month. Market cap is $267.9M, with 13.7 days to cover in short interest.

Stock performance

How Ocugen, Inc. Common Stock (OCGN) stock has performed from one day to one year, with its 52-week range.

-6.25%
-$0.05 over 1D
$0.74$0.76$0.78$0.804:50 AM10:05 AM12:25 PM2:40 PM5:15 PM$0.75
1D
-6.37%
1W
-5.20%
1M
-26.03%
YTD
-45.21%
1Y
-54.06%
52-wk range
$0.73 – $2.73

Key statistics

Today's trading snapshot for OCGN: day range, open, previous close, volume and market cap.

Day range
$0.73 – $0.80
Open
$0.80
Prev close
$0.79
Volume
8.58M
Market cap
$267.9M
Shares out
339.11M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Ocugen, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
56.13
P/B
-16.18
P/FCF
—
ROE
387.2%
ROA
-51.6%
Debt/Equity
-5.08
Div yield
0.00%

As of Oct 22, 2026

8-K filings

Material corporate events Ocugen, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Deal agreementsOct 15, 2026

    On October 13, 2026, Ocugen, Inc. entered into an Exclusive License Agreement with Roots Pharmaceutical Company WLL, pursuant to which Roots was granted an exclusive, non-sublicensable, royalty-bearing license to exploit OCU400 in certain countries in the Middle East and North Africa.

  • Investor communicationsOct 15, 2026

    Attached as Exhibit 99.1 and incorporated herein by reference is a presentation that Ocugen, Inc. ... will post on its website on October 15, 2026 and may use from time to time in presentations or discussions with investors, analysts, and other parties.

  • Shareholder meetingsSep 23, 2026

    On September 21, 2026, Ocugen, Inc. held a Special Meeting of Stockholders, which was adjourned to October 5, 2026 solely with respect to the proposal to approve the adoption of an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock by 250,000,000 shares. Proposal 2, approving the adjournment to solicit additional proxies, was approved by the Company's stockholders.

  • Investor communicationsSep 8, 2026

    Attached as Exhibit 99.1 and incorporated herein by reference is a presentation that Ocugen, Inc. ... will post on its website on September 8, 2026 and may use from time to time in presentations or discussions with investors, analysts, and other parties.

  • Investor communicationsAug 6, 2026

    The Company will use presentation materials in connection with the conference call and webcast, which presentation materials will be posted on the Company's website at www.ocugen.com. Copies of the press release and presentation materials are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively.

OCGN short interest

How heavily OCGN is shorted: shares short, days to cover and average daily volume.

Days to cover
13.7
Short interest
102.05M
Avg volume
7.47M

As of · reported to FINRA twice monthly.

OCGN news

The latest news and headlines about Ocugen, Inc. Common Stock (OCGN).

Frequently asked questions

What is the Ocugen, Inc. Common Stock (OCGN) stock price today?

Ocugen, Inc. Common Stock (OCGN) is trading at $0.7397 (-6.37% on the day) as of 5:15:12 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Ocugen, Inc. Common Stock?

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe.

What is the short interest in OCGN?

As of Sep 30, 2026, OCGN has 102.05M shares short and 13.7 days to cover.

What exchange is OCGN listed on?

Ocugen, Inc. Common Stock (OCGN) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

Build with AI

Build an analysis of OCGN with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a OCGN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.